128
FDA Scrutiny: A Harbinger of Accelerated Drug Development Oversight?
Nearly 40% of Americans currently take prescription drugs, a figure that continues to climb alongside an aging population and the rise of chronic diseases. But the system designed to ensure those drugs are safe and effective is showing cracks. The recent, highly publicized departure of Dr. Edie Medrano, former Director of the FDA’s Division of Pulmonary and Allergy Drugs, isn’t an isolated incident; it’s a symptom of a deeper malaise within the agency, and a potential catalyst for significant change.
The Fallout: Beyond a ‘Toxic’ Environment
Reports from the New York Times, STAT News, Reuters, and the
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
